Sermorelin Cost: What You'll Actually Pay in 2026

Executive Summary

Sermorelin is one of the most commonly prescribed growth hormone secretagogues in the men's health clinic space — and one of the most inconsistently priced. You can find sermorelin programs advertised starting at $99/month and others charging $500+ for the same compound. That range is not arbitrary: it reflects real differences in what each program includes, the pharmacy source behind the medication, and the clinical oversight model attached to it.

The key context for 2026 is the February 27, 2026 HHS reclassification announcement, which is expected to return sermorelin and most other growth hormone secretagogues (including ipamorelin, CJC-1295, and BPC-157) from the restricted Category 2 list back to Category 1, where they can be legally compounded by 503A and 503B pharmacies. Sermorelin was less affected than some other peptides during the Category 2 period — it already had an FDA approval history (Geref) which gave some compounders a clearer legal path — but the reclassification is expected to further expand access and stabilize supply. For buyers, that means more clinic competition and potentially better pricing over H2 2026, though costs in early 2026 reflect current market rates.

This guide breaks down sermorelin pricing across all care paths, compares it to ipamorelin and CJC-1295/ipamorelin stack pricing, and gives you the tools to evaluate whether a specific program is competitively priced for what it actually delivers. For the full evidence and dosing picture behind the compound, see sermorelin vs ipamorelin vs CJC-1295. For clinic evaluation criteria, see best peptide clinics online 2026.

At-a-Glance Comparison

Sermorelin cost by clinic model in 2026. Costs vary based on program structure, pharmacy sourcing, and whether monitoring is included. All figures are approximate 2026 market rates. Post-Feb 2026 reclassification expected to normalize supply and increase competition in H2 2026.

Why sermorelin pricing varies so widely — and what actually drives the difference

The sermorelin pricing spread you see online — from $99/month to $600/month — is not primarily explained by clinic profit margins. It is explained by three structural differences: what is included in the monthly price, the quality of the compounding pharmacy source, and the depth of clinical oversight attached to the protocol. Buyers searching for sermorelin cost usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Sermorelin is a 29-amino-acid peptide that stimulates the pituitary to produce endogenous growth hormone. The compound itself is not expensive to produce at a licensed compounding pharmacy — a 30-day supply at standard protocol dosing (200–500 mcg nightly subcutaneous) costs the pharmacy well under $100 in raw material. The variation in retail pricing comes from what surrounds the compound: physician time, lab panels, monitoring infrastructure, and pharmacy quality. The lowest-priced programs ($99–$199/month) typically get there by minimizing one or more of these: they skip required labs, use an unlisted compounding pharmacy, deliver minimal clinical oversight (often async messaging only), or exclude monitoring visits from the monthly price. That does not automatically make them bad programs — some are genuinely efficient telemedicine models with real clinical quality behind a low operational cost structure. But the floor price is a signal worth investigating, not a reason to stop asking questions. The highest-priced programs ($400–$600/month) at specialist peptide clinics like Marek Health or Defy Medical typically include physician-level evaluation, a comprehensive IGF-1 and hormone panel at baseline and follow-up, a compounded formulation sourced from a named pharmacy with documented chain of custody, and structured monitoring check-ins. Whether that is worth the premium depends entirely on your clinical situation. For context on the February 2026 FDA reclassification and what it means for clinic supply chains, see BPC-157 and TB-500: what the research actually shows for the broader reclassification picture. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: buyers assume that a lower monthly sermorelin price means an equivalent product at better value. In most cases, it means a shorter accountability chain, less rigorous sourcing documentation, or reduced monitoring. The risk is paying $100/month for three months and having no idea whether the protocol is working. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Sermorelin vs ipamorelin vs CJC-1295/ipamorelin: cost comparison

Sermorelin is usually the cheapest entry point into growth hormone secretagogue therapy, but the cost difference between sermorelin and ipamorelin or a CJC-1295/ipamorelin combination stack is smaller than most buyers expect. Buyers searching for sermorelin cost usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

At standard clinic pricing, the compound cost difference between sermorelin monotherapy and ipamorelin monotherapy is typically $0–$50/month when sourced from the same pharmacy. CJC-1295/ipamorelin combination protocols — where CJC-1295 provides sustained GHRH elevation and ipamorelin provides a discrete GH pulse — typically cost $50–$150/month more than sermorelin monotherapy, depending on the clinic and the specific protocol structure. The reason for the modest difference is that all three compounds are produced by licensed compounding pharmacies using relatively inexpensive raw materials, and the cost difference in compound production is small relative to the overhead of clinical services. The more meaningful cost difference is in the clinical logic behind each choice: sermorelin monotherapy is appropriate for patients who want a simple, lower-dose GHRH approach; ipamorelin adds a selective GHRP component; CJC-1295/ipamorelin is a combination protocol targeting more pronounced and sustained GH pulses, which is why specialist clinics tend to charge more for it — the protocol is more complex, not just the compound. From a pure cost standpoint, if you are trying to minimize cost and a clinic offers both sermorelin and ipamorelin at similar prices, the protocol decision should be made on clinical grounds, not on the assumption that sermorelin is meaningfully cheaper. For the full protocol comparison including half-lives, GH pulse mechanisms, and who each compound is appropriate for, see sermorelin vs ipamorelin vs CJC-1295. For timeline expectations across all three, see how long do peptide results take. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: buyers choose sermorelin over ipamorelin or CJC-1295/ipamorelin primarily to save money, without realizing that the cost difference is small and the protocol difference is clinically meaningful. Optimizing for compound cost rather than clinical fit is the wrong frame for a 3–6 month commitment. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

What a realistic sermorelin budget looks like across a 6-month protocol

Sermorelin is a long-protocol therapy. Meaningful body composition and recovery benefits typically take 3–6 months to appear at clinical doses. Budgeting in one-month increments underestimates what you will actually spend. Buyers searching for sermorelin cost usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

A realistic 6-month sermorelin program budget depends on which clinic model you choose. Telemedicine / convenience clinic path: initial consultation ($99–$199), baseline labs (often skipped or $75 self-ordered), monthly medication × 6 ($99–$199/mo), one follow-up IGF-1 check ($75–$100). Total range: $750–$1,500. Note that the low end of this range often represents reduced monitoring and uncertain pharmacy sourcing — things that matter for both efficacy tracking and safety. TRT-plus expansion clinic path: initial consultation ($0–$150, often bundled), baseline IGF-1 + hormone panel ($100–$200), monthly medication × 6 ($150–$250/mo), quarterly monitoring visits × 2 ($150 total). Total range: $1,150–$2,000. Specialist peptide clinic path (Marek Health, Defy Medical-tier): initial physician evaluation ($300–$400), comprehensive baseline labs ($200–$300), monthly compounded sermorelin × 6 ($250–$450/mo), structured IGF-1 monitoring at 3 and 6 months ($150–$250 total). Total range: $2,200–$3,700. The key budget insight is that the 6-month specialist cost is 2–4× the telemedicine cost, but what you are buying for that difference is a real baseline (so you can measure whether the protocol worked), documented pharmacy sourcing (so you know the compound is what it claims to be), and structured IGF-1 monitoring (so you have evidence of GH response, not just subjective feeling). For men using sermorelin as a longevity or body-composition protocol with a clear measurement framework, the specialist model tends to produce better clinical decision-making. For men who want to try a lower-cost entry point and are comfortable with less measurement, the telemedicine path is the more affordable option. For the full spectrum of peptide program evaluation criteria, see best peptide clinics online 2026. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: buyers underestimate 6-month total cost by planning around monthly headline prices and forgetting the initial evaluation and lab costs that front-load the first month. The actual first-month spend at almost any legitimate clinic is 2–3× the monthly medication cost. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

The compounding pharmacy question: why it matters for sermorelin pricing

The compounding pharmacy behind a sermorelin program is the most important cost-quality variable that most clinic marketing does not mention. It is also the clearest signal of whether a low-priced program is acceptably cheap or dangerously cheap. Buyers searching for sermorelin cost usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Sermorelin's legal standing in 2026 is cleaner than most other growth hormone secretagogues. Its prior FDA approval history (as Geref) means that licensed 503A and 503B compounding pharmacies have a clearer regulatory path for compounding it — even during the Category 2 restriction period that applied to ipamorelin, CJC-1295, and BPC-157. That is good news for buyers because it means more pharmacy competition, more supply stability, and better pricing pressure at the pharmacy level. It also makes it easier to find a clinic that can clearly name their pharmacy source. A named, FDA-registered compounding pharmacy is the baseline expectation for any legitimate sermorelin program. Clinics that compound from unlisted sources, use bulk raw-material suppliers directly, or cannot document their pharmacy sourcing are operating in a gray zone that creates real risk: contamination, inconsistent potency, and no accountability chain if the compound causes a problem. The cost implications are direct: programs using pharmacy-grade compounded sermorelin typically cost $150–$450/month for the medication; programs that cut corners on pharmacy sourcing can price at $75–$130/month for what they claim is the same compound. Whether they actually are the same compound — same purity, same sterility, same potency — is exactly what you cannot verify without pharmacy documentation. The practical step: before committing to any sermorelin program, ask the clinic for the name of their compounding pharmacy and request a Certificate of Analysis for your medication. Legitimate specialist clinics can provide this. Clinics that cannot should be disqualified regardless of pricing. For a broader sourcing accountability framework, see peptide therapy side effects and safety. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: buyers treat sermorelin as equivalent across all programs because it is the same peptide name. The compound is only equivalent if the pharmacy sourcing is equivalent — which it is not across all clinic models. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Red flags in sermorelin program pricing: what underpriced and overpriced both look like

Not all low-cost sermorelin programs are bad. And not all high-cost programs are good. There are specific pricing patterns that reliably predict poor clinical quality in either direction. Buyers searching for sermorelin cost usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

The clearest underpriced red flags in sermorelin programs are: no baseline IGF-1 or hormone panel requirement (which means you have no clinical baseline and no way to measure response), no named compounding pharmacy (which means no accountability chain for what you are injecting), consultation that is purely asynchronous questionnaire-based without any physician or PA review of your labs, and monthly pricing below $120 for the compound (which is below cost for legitimate 503A/503B pharmacy-sourced sermorelin at standard dosing). The clearest overpriced red flags are: programs that require bundled add-ons — supplements, compounded nutrient blends, NAD+ combinations — without clear clinical indication for your situation, monthly subscription structures that auto-renew regardless of whether you are on an active protocol, and programs that charge premium specialist prices without offering the specialist-quality evaluation and monitoring that justifies the rate. The most reliable signal of appropriate pricing is transparent itemization: a good program can tell you exactly what the consultation costs, what the labs cost, what the medication costs per month, and what the monitoring costs. Programs that only offer a bundled monthly number without line-item clarity are hiding cost structure information that would allow you to make a fair comparison. For the full clinic evaluation rubric — covering evaluation quality, sourcing, monitoring, and pricing transparency — see best peptide clinics online 2026. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: buyers equate clinic credibility with clinic cost and assume that expensive programs are automatically higher quality. Specialist clinic pricing is not self-validating — it requires verification of the specific evaluation, pharmacy sourcing, and monitoring quality that is supposed to justify the rate. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

How to shortlist the right sermorelin program for your budget and goals

Cost is a valid filter — but it should be the last filter you apply, after you have confirmed evaluation quality, pharmacy sourcing, and monitoring structure. Starting with cost leads to programs optimized for low headline pricing, not clinical quality. Buyers searching for sermorelin cost usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

The most efficient sermorelin shortlisting process works in four steps. Step 1: Define your care goals and protocol length. Are you primarily targeting sleep quality and body composition? Recovery from a specific injury? Longevity and energy? The protocol goal determines what monitoring matters and how long you are realistically committing to spend. A 3-month trial has a different budget than a 12-month longevity protocol. Step 2: Filter by evaluation quality. Confirm that the initial consultation involves a physician or advanced practitioner who reviews your labs — not just a questionnaire. Confirm that IGF-1 is tested at baseline. This step eliminates the convenience-only, questionnaire-based programs that cannot actually support clinical decision-making. Step 3: Filter by pharmacy sourcing. Ask for the pharmacy name. Ask whether it is 503A or 503B registered. Ask for a COA on request. This eliminates programs that cut corners on compound accountability. Step 4: Compare total 6-month cost across the programs that passed steps 2 and 3. At this point, you are comparing programs that have already cleared the quality bar — price becomes a meaningful tiebreaker between genuinely equivalent options. Programs that survive all three prior filters typically land in the $1,200–$2,500 range for a real six-month protocol. If a program is dramatically cheaper than that and passed your quality filters, ask specifically what they are doing differently in the cost model. Sometimes it is a genuinely efficient telemedicine infrastructure. More often it is a compromise in lab depth, monitoring cadence, or pharmacy documentation. To begin your shortlist with evaluated clinic profiles, see our provider comparison tool or start with best peptide clinics online 2026. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: buyers start shortlisting on price and discover disqualifying quality problems after they have already paid an initial consultation fee or started a protocol. Quality filters applied first protect you from this. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Internal Resources to Compare Next

Use these pages to validate assumptions before spending. Cross-checking provider model details with treatment-specific pages is the fastest way to reduce preventable cost drift in month two and month three.

Compare Providers Before You Purchase

Ready to compare sermorelin programs that have cleared the evaluation quality, pharmacy sourcing, and monitoring bar? Use our provider comparison tool to shortlist clinics based on what actually matters — not just the lowest advertised monthly number.

Disclosure: PeakedLabs may earn a commission from partner links. Editorial scoring and rankings remain independent.

Frequently Asked Questions

How much does sermorelin cost per month?

Sermorelin medication from a licensed compounding pharmacy typically costs $100–$450 per month depending on the clinic model. Telemedicine-first programs often price at $99–$199/month but may exclude consultation, labs, or monitoring from that figure. Specialist peptide clinics typically price the medication at $200–$450/month as part of a supervised program that includes evaluation and monitoring. The monthly medication cost alone does not tell you the full program cost.

What does a full 6-month sermorelin program cost?

A realistic 6-month sermorelin program runs $750–$1,500 at telemedicine-first clinics (low oversight model), $1,150–$2,000 at TRT-plus expansion clinics, and $2,200–$3,700 at specialist peptide practices like Marek Health or Defy Medical. The difference reflects evaluation depth, pharmacy sourcing quality, and monitoring rigor — not just margin. Always budget in 6-month blocks because sermorelin is a long-protocol therapy.

Is sermorelin cheaper than ipamorelin?

Marginally, but the difference is smaller than most buyers expect — typically $0–$50/month at clinics using equivalent pharmacy sourcing. A CJC-1295/ipamorelin combination stack typically costs $50–$150/month more than sermorelin monotherapy. The choice between sermorelin and ipamorelin should be made on clinical protocol grounds, not on cost optimization — the price delta is too small to meaningfully affect a 6-month budget.

Does insurance cover sermorelin?

No. Sermorelin is not covered by standard health insurance when prescribed for anti-aging, body composition, or performance optimization. Some HSA/FSA accounts may cover consultation fees if a licensed physician is involved and documentation is appropriate, but the peptide medication itself is not covered. Budget for full out-of-pocket cost.

What labs do I need before starting sermorelin and what do they cost?

A minimum baseline at a legitimate clinic includes IGF-1 (the primary efficacy marker for growth hormone stimulation), total and free testosterone, thyroid panel, CBC, and metabolic panel. At specialist clinics, a comprehensive baseline panel runs $150–$300. At telemedicine programs, labs may cost $75–$150 or be skipped entirely. If a clinic does not require an IGF-1 baseline before starting you on sermorelin, you have no way to measure whether the protocol is working — that is a meaningful clinical red flag.

How do I know if a sermorelin program is legitimately priced?

Ask for an itemized breakdown: consultation cost, lab cost, monthly medication cost, and monitoring structure and cost. Any legitimate clinic can provide this. Compare total 6-month cost between programs that have passed your quality filters (evaluation depth, named pharmacy, IGF-1 monitoring) — not monthly headline prices between programs with different oversight models. Programs that survived quality filtering and land below $1,000 for a real 6-month program are almost certainly cutting a corner somewhere.

What does the February 2026 FDA reclassification mean for sermorelin pricing?

On February 27, 2026, HHS announced that most restricted peptides — including ipamorelin and CJC-1295 — are expected to return to Category 1, where they can be legally compounded by 503A and 503B pharmacies. Sermorelin was already in a cleaner legal position due to its prior FDA approval history, but the broader reclassification is expected to expand clinic supply options and create pricing pressure over H2 2026. For buyers in early 2026, current market prices reflect the pre-reclassification supply environment — expect more competition and potentially better pricing later in the year.

What red flags indicate an underpriced or poor-quality sermorelin program?

Key red flags: no IGF-1 baseline required before starting, no named compounding pharmacy (or inability to provide COA on request), consultation that is purely a questionnaire with no physician review of your labs, and medication pricing below $120/month (which is below realistic cost for 503A/503B pharmacy-sourced sermorelin at standard dosing). These patterns reliably predict compromised clinical quality, sourcing accountability, or monitoring — regardless of how the program is marketed.

How does sermorelin cost compare to HGH injections?

Sermorelin is significantly cheaper than pharmaceutical HGH (somatropin). Prescribed HGH injections typically cost $500–$2,000+ per month for the medication alone, compared to $100–$450/month for clinic-supervised sermorelin. The mechanism is different — sermorelin stimulates your pituitary to produce endogenous GH rather than delivering exogenous HGH — and the regulatory pathway is different (sermorelin is legally compoundable; pharmaceutical HGH is tightly controlled). For most men interested in GH optimization, sermorelin or a CJC-1295/ipamorelin protocol is both more accessible and more affordable.

Can I get sermorelin without a prescription or through a research vendor?

Sermorelin requires a prescription from a licensed physician in the US — it is not available legally through research peptide vendors the way some other compounds are marketed. The research-vendor gray market that exists for BPC-157 and TB-500 does not meaningfully apply to sermorelin because it has a clearer prescription-only regulatory history. The practical implication is that all legitimate sermorelin programs involve a physician evaluation and a licensed compounding pharmacy — and programs that skip this are operating outside the appropriate legal framework.